Thursday, October 20, 2016

FDA Approves Genentech's Cancer Immunotherapy Tecentriq (Atezolizumab) for People with a Specific Type of Metastatic Lung Cancer

… advanced lung cancer have been consistently improving,” said Bonnie J. Addario, a lung cancer survivor and founder of the Bonnie J. Addario Lung Cancer Foundation … in lung cancer, including seven Phase III studies in previously untreated (first-line) lung cancer

No comments:

Post a Comment